[脾喷汀(DA SP-5)在银屑病关节病患者中的治疗应用]。

Dermatologische Monatschrift Pub Date : 1990-01-01

J Greiner, M Miehe, H Weber, A Stoimenov, N Sönnichsen, W Diezel

{"title":"[脾喷汀(DA SP-5)在银屑病关节病患者中的治疗应用]。","authors":"J Greiner, M Miehe, H Weber, A Stoimenov, N Sönnichsen, W Diezel","doi":"","DOIUrl":null,"url":null,"abstract":"8 patients with confirmed psoriatic arthritis were treated with splenopentin for 12 months. A relief of joint pain could be detected under this treatment both after 6 weeks (improvement of the Ritchie-indices: 44%) and after 12 months (improvement: 28%). In contrast to this, X-ray investigations show a worsening of the disease after 12 months. Therefore we conclude that splenopentin alone is not a sufficient therapeutic drug in patients suffering from psoriatic arthritis.","PeriodicalId":11046,"journal":{"name":"Dermatologische Monatschrift","volume":"176 2-3","pages":"157-62"},"PeriodicalIF":0.0000,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Therapeutic use of splenopentin (DA SP-5) in patients with psoriasis arthropathica].\",\"authors\":\"J Greiner, M Miehe, H Weber, A Stoimenov, N Sönnichsen, W Diezel\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"8 patients with confirmed psoriatic arthritis were treated with splenopentin for 12 months. A relief of joint pain could be detected under this treatment both after 6 weeks (improvement of the Ritchie-indices: 44%) and after 12 months (improvement: 28%). In contrast to this, X-ray investigations show a worsening of the disease after 12 months. Therefore we conclude that splenopentin alone is not a sufficient therapeutic drug in patients suffering from psoriatic arthritis.\",\"PeriodicalId\":11046,\"journal\":{\"name\":\"Dermatologische Monatschrift\",\"volume\":\"176 2-3\",\"pages\":\"157-62\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1990-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Dermatologische Monatschrift\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dermatologische Monatschrift","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

8例确诊为银屑病关节炎的患者用脾喷丁治疗12个月。6周后(里奇指数改善:44%)和12个月后(改善:28%)，在这种治疗下，关节疼痛可以得到缓解。与此相反，x光检查显示12个月后病情恶化。因此，我们认为单独使用脾喷丁治疗银屑病关节炎是不够的。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

微信好友朋友圈 QQ好友复制链接

本刊更多论文

[Therapeutic use of splenopentin (DA SP-5) in patients with psoriasis arthropathica].

8 patients with confirmed psoriatic arthritis were treated with splenopentin for 12 months. A relief of joint pain could be detected under this treatment both after 6 weeks (improvement of the Ritchie-indices: 44%) and after 12 months (improvement: 28%). In contrast to this, X-ray investigations show a worsening of the disease after 12 months. Therefore we conclude that splenopentin alone is not a sufficient therapeutic drug in patients suffering from psoriatic arthritis.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Dermatologische Monatschrift

自引率

0.00%

发文量